Halozyme Therapeutics
HALO
#1703
Rank
S$15.94 B
Marketcap
S$140.50
Share price
2.73%
Change (1 day)
52.09%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): S$0.75 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$1.66 Billion. In 2025 the company made an earning of S$0.59 Billion a decrease over its 2024 earnings that were of S$0.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.75 B26.17%
2025 S$0.59 B-16.2%
2024 S$0.71 B59.94%
2023 S$0.44 B39.94%
2022 S$0.31 B0.16%
2021 S$0.31 B92.2%
2020 S$0.16 B-278.96%
2019 -S$92.41 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$78.79 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$41.23 Million-52.86%
2014 -S$87.45 Million-18.09%
2013 -S$0.11 Billion55.88%
2012 -S$68.49 Million169.94%
2011 -S$25.38 Million-63.44%
2010 -S$69.4 Million-7.19%
2009 -S$74.77 Million15.91%
2008 -S$64.51 Million83.89%
2007 -S$35.08 Million78.1%
2006 -S$19.7 Million16%
2005 -S$16.98 Million45.24%
2004 -S$11.69 Million682.42%
2003 -S$1.5 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.51 B 4,392.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.83 B 1,084.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$42.96 B 5,659.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.15 B 1,127.47%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-S$0.62 Billion-182.80%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-S$62.23 Million-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA